Crum Brian T

CIK 00017927471 companyTHE WOODLANDS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001792747

Recent Transactions

50 trades

Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28+26,097→ 203,594 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28+69,387→ 306,437 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-28−33,456→ 33,457 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28+33,456→ 237,050 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-28−26,097→ 0 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2025-02-28$0.67/sh−45,622→ 260,815 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-28−69,387→ 138,773 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2025-02-13+765,730→ 765,730 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2025-02-13+510,490→ 510,490 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−33,457→ 66,913 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−26,096→ 26,097 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−8,750→ 0 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28$2.62/sh−25,604→ 177,497 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+26,096→ 169,644 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+33,457→ 203,101 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+8,750→ 143,548 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2024-02-08+208,160→ 208,160 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-08+208,160→ 208,160 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−8,750→ 8,750 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+26,097→ 155,335 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+8,750→ 129,238 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28$2.17/sh−20,537→ 134,798 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−26,097→ 52,193 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−21,030→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+21,030→ 120,488 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-09+100,370→ 100,370 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2023-02-09+301,100→ 301,100 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+11,100→ 84,737 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+21,030→ 105,767 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28+8,750→ 114,517 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-02-28$2.85/sh−15,059→ 99,458 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−11,100→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−21,030→ 21,030 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-28−8,750→ 17,500 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2022-02-10+234,870→ 234,870 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2022-02-10+78,290→ 78,290 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−1,517→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−5,118→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+1,517→ 51,249 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+5,118→ 56,367 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+11,100→ 67,467 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−21,030→ 42,060 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−11,100→ 11,100 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28$7.19/sh−14,860→ 73,637 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+21,030→ 88,497 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-11+26,250→ 26,250 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2021-02-11+78,760→ 78,760 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22+19,893→ 56,130 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22$1.96/sh−6,398→ 49,732 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-28−1,518→ 1,517 total

Companies

LEXICON PHARMACEUTICALS, INC.
SVP, General Counsel & Secr.
$LXRX

Recent Filings

Address

2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR

THE WOODLANDS, TX, 77381

View on SEC.gov